Executives from SinoMab BioScience attend the company’s IPO press conference, in Central on Wednesday. Photo: Jonathan Wong

Two more companies set to raise up to US$250 million as Hong Kong marches ahead in retaining IPO crown

  • SinoMab BioScience, a home-grown Hong Kong biopharma company, is aiming to raise up to HK$1.75 billion
  • China PengFei Group, the world’s largest supplier of rotary kilns used to make construction materials, is seeking to raise up to HK$197.5 million
Topic |   IPO
Executives from SinoMab BioScience attend the company’s IPO press conference, in Central on Wednesday. Photo: Jonathan Wong
READ FULL ARTICLE